Post-discharge antithrombotic management and clinical outcomes of patients with new-onset or pre-existing atrial fibrillation and acute coronary syndromes undergoing coronary stenting: Follow-up data of the MATADOR-PCI study

Published: 7 April 2021

Author(s): Leonardo De Luca, Andrea Di Lenarda, Andrea Rubboli, Leonardo Bolognese, Lucio Gonzini, Federico Fortuni, Alessandro Navazio, Fabrizio Poletti, Antonietta Ledda, Stefano Urbinati, Domenico Gabrielli, Michele Massimo Gulizia, MATADOR-PCI Investigators

Issue: June 2021

Section: Original article

Read on EJIM website

. Patients with concomitant atrial fibrillation (AF) and acute coronary syndromes (ACS) do not seem to receive proper antithrombotic therapies and present high rates of adverse clinical events.

Post-discharge antithrombotic management and clinical outcomes of patients with new-onset or pre-existing atrial fibrillation and acute coronary syndromes undergoing coronary stenting: Follow-up data of the MATADOR-PCI study

Newsletters

Latest Newsletters

You are here

Post-discharge antithrombotic management and clinical outcomes of patients with new-onset or pre-existing atrial fibrillation and acute coronary syndromes undergoing coronary stenting: Follow-up data of the MATADOR-PCI study

Newsletters

Latest Newsletters